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GLOSSARY
BIS = bispectral index; CDS = clinical decision support system; EEG = electroencephalogram; 
HSS = hybrid sedation system; MIMO = multiple input multiple output; SISO = single input single 
output; TCI = target-controlled infusion
BACKGROUND: THE RATIONALE FOR ROBOTS IN 
ANESTHESIA
Robots now surround our daily activities, doing every-
thing from cleaning our homes to flying airplanes, and 
they exist in fields ranging from industry to medicine. 
In science fiction, we tend to conceptualize “robots” as 
human-shaped automata, but in general, a “robot” gen-
erally refers to any mechanical system capable of inter-
acting with the environment with directed interventions.
In medicine, automation offers precision therapy 
in combination with a high level of reproducibility. 
These features make robots appealing in the medi-
cal fields, and they have been used in the field of 
anesthesia for several decades assisting clinicians.1,2 
However, many well-tested autonomous systems and 
known to be safe have not been adopted yet into clini-
cal practice on a daily basis. When we consider that 
repetitive execution of trivial technical tasks is subject 
to vigilance decrement in humans, as well as the fact 
that human providers may suffer from fatigue, bore-
dom, and bias, there is a strong rationale for the role 
such systems may play in clinical care.3,4 Using robots 
to assist in the acquisition of patient data, simple deci-
sion-making, and manual tasks may leave physicians 
freer to focus efficiently on tasks requiring human 
intelligence and judgment.5
As most of us are aware, almost every facet of our society is becoming, for better or worse, 
progressively more technology-dependent. Technological advancement has made autonomous 
systems, also known as robots, an integral part of our life in several fields, including medicine. 
The application of robots in anesthesia could be classified into 3 types of robots. The first ones 
are pharmacological robots. These robots are based on closed-loop systems that allow better-
individualized anesthetic drug titration for optimal homeostasis during general anesthesia and 
sedation. Recent evidence also demonstrates that autonomous systems could control hemody-
namic parameters proficiently outperforming manual control in the operating room. The second 
type of robot is mechanical. They enable automated motorized reproduction of tasks requir-
ing high manual dexterity level. Such robots have been advocated to be more accurate than 
humans and, thus, could be safer for the patient. The third type is a cognitive robot also known 
as decision support system. This type of robot is able to recognize crucial clinical situation that 
requires human intervention. When these events occur, the system notifies the attending clini-
cian, describes relevant related clinical observations, proposes pertinent therapeutic options 
and, when allowed by the attending clinician, may even administer treatment. It seems that 
cognitive robots could increase patients’ safety. Robots in anesthesia offer not only the possi-
bility to free the attending clinicians from repetitive tasks but can also reduce mental workload 
allowing them to focus on tasks that require human intelligence such as analytical and clinical 
approach, lifesaving decision-making capacity, and interpersonal interaction. Nevertheless, fur-
ther studies have yet to be done to test the combination of these 3 types of robots to maintain 
simultaneously the homeostasis of multiple biological variables and to test the safety of such 
combination on a large-scale population.  (Anesth Analg 2020;130:1120–32)
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At present, in the field of anesthesiology, we find 
primarily 3 different kinds of robots.6 The first 2 types, 
pharmacological and mechanical (or manual) robots, 
are designed to eliminate the repetitive part of the 
workload by automating simple tasks and giving 
support to the clinician, respectively. The third cate-
gory of robots, broadly referred to herein as “artificial 
intelligence” systems, offer updated and pertinent 
recommendations related to specific clinical scenarios 
detected automatically. They could either help phy-
sicians identifying promptly critical actions in emer-
gency scenarios or even respond autonomously if 
allowed. The integration of these robots into clinical 
practice aims to assist the attending clinician increas-
ing accuracy and safety of the care delivered.
This article first provides an overview of the most 
recent advancements of each type of robot in anes-
thesiology and then hypothesize as to their future 
application.
PHARMACOLOGICAL ROBOTS
Pharmacological Robots: How Do They Work?
Pharmacological robots in anesthesia are designed 
around the concept of maintaining patient homeo-
stasis by keeping specific parameters of interest (eg, 
blood pressure or hypnosis) as close as possible to a 
defined target value. In some ways, target-controlled 
infusion (TCI) systems were the first pharmacologi-
cal robots. These robots use software that, rather than 
delivering a steady rate infusion, deliver loading 
boluses designed to more rapidly obtain a specific 
plasmatic drug concentration. These boluses are then 
followed by automatic changes of the infusion rate to 
maintain the drug concentration chosen by the practi-
tioner. These robots calculate both the boluses and the 
infusion rates based on a pharmacokinetic model of 
the drug used.7 Of note, a clinically appealing option 
of TCI devices is that they can theoretically be pro-
grammed to take into account the time lag between 
the plasma infusion and the site of action in the brain. 
However, TCI systems have major limits because they 
use pharmacokinetic models derived from studies that 
were not intended for specific clinical procedures and 
for patients with extreme anthropomorphic charac-
teristics.8 The newest types of pharmacological robots 
achieve patient homeostasis through titration of anes-
thetic drugs via the robot’s rapid calculation of current 
need and adjustment of drug delivery.9 These versions 
of pharmacological robots use closed-loop systems that 
allow marginal reaction delay and minimal amplitude 
excursion from the desired target resulting in better 
performance compared to both manually adminis-
tered intravenous anesthesia and TCI delivery.10,11
Pharmacologic robots use algorithms that may 
range in complexity from simple linear transforma-
tion to complex machine-learning algorithms. The 
aim of these control systems is to reach a set “goal” 
for the controlled variable of relevance (arterial pres-
sure, heart rate, electroencephalogram monitor, etc). 
Therefore, these control systems compare a measured 
value of the controlled variable (the target) against 
that “goal” and adjust the actuator (the drug delivery 
mechanism) to reduce the gap between “goal” and 
actual value (Figure 1). For clarity, it has to be under-
lined that some research groups have developed 
closed-loop systems that include TCI technology in 
their algorithms.12
Pharmacological Robots in Anesthesia
In anesthesiology, pharmacological robots have been 
designed mainly to induce and maintain the 3 compo-
nents of general anesthesia: hypnosis, analgesia, and 
neuromuscular block.13 However, there are both his-
torical and more recent investigations showing that 
pharmacological robots could effectively maintain 
other parameters of anesthetic interest such as blood 
pressure.2,14–16 Indeed, the first closed-loop system 
described, that was also commercially available, has 
been designed for autonomous control of blood pres-
sure (Figure 2).
Pharmacological Robots for General Anesthesia
The first investigations using pharmacological robots 
in anesthesia were performed more than 65 years ago.17 
At that time, few trials testing pharmacological robots 
were performed because of the technical limitations 
of monitoring and custom pump control at that time. 
In the mid-90s, the progress in computing and the 
introduction of processed electroencephalogram indi-
ces such as the bispectral index (BIS; Aspect Medical 
System, Inc, Newton, MA) monitor to measure more 
objectively the depth of anesthesia opened the door 
more widely to this field of investigation. At an early 
stage, pharmacological robots were designed for a sin-
gle drug using a single-loop system also known as sin-
gle input single output (SISO) systems. More recently, 
pharmacological robots are able to analyze multiple 
inputs adjusting automatically to multiple outputs. 
The latter multiple-loop systems are also known as 
multiple input multiple output (MIMO) systems.13
Single Closed-Loop System for General Anesthesia: 
SISO. Initially, closed-loop systems that were most 
commonly studied were conceived mainly for the 
control of hypnosis and muscle relaxation because 
no monitor was able to reliably assess pain during 
general anesthesia.18 At the beginning of the present 
century, Gentilini et al19 showed that maintenance 
of hypnosis using single closed-loop system for 
isoflurane was feasible. Soon after, Locher et al20 
demonstrated that maintenance of hypnosis using 
closed-loop system for isoflurane could perform better 
Copyright © 2020 International Anesthesia Research Society. Unauthorized reproduction of this article is prohibited.
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than manual control. Concurrently, other research 
groups developed closed-loop systems for propofol 
using a variety of mathematical algorithms for robotic 
drug delivery.21 In 2001, Struys et al22 demonstrated 
that induction and maintenance of hypnosis using a 
patient individualized model-based adaptive closed-
loop control system for propofol is feasible. In their 
randomized trial, 10 patients received automated 
administration of propofol setting the target BIS value 
at 50. Patients in the automated delivery group had 
less overshoot of the BIS target, less drop of blood 
pressure, and faster extubation time compared to the 
other 10 patients who had the propofol administration 
controlled manually. They enhanced their initial 
algorithm by incorporating Bayesian optimization 
technology23 and illustrated feasibility and usability 
in various experimental24 and clinical situations.25–27 
In 2006, Liu et al28 developed a pharmacological robot 
using a closed-loop titration of propofol TCI based on 
a proportional-integral-differential algorithm. In their 
trial, they compared their system to a TCI system 
for propofol administration. They have shown that 
automated delivery of propofol could reduce BIS 
overshoot and propofol consumption compared to 
TCI. In 2007, Puri et al29 developed a closed-loop 
anesthesia delivery system integrating a model-based 
adaptive algorithm and showed their system to be 
efficient in difficult environments30 and for complex 
surgery in both adult31 and pediatric subjects.32 In 
2010, Hemmerling et al33  described a novel single 
closed-loop system for propofol administration, 
which has been demonstrated to outperform manual 
administration. This system has an adaptive, rule-
based algorithm, which takes into account a set of 
rules aiming to reach and maintain the target. These 
rules aim to increase the hysteresis control, including 
different factors of clinical importance such as the 
surgery period, previous adjustments, BIS trend, 
BIS artifacts, and maximum and minimum dosing 
allowance. In 2011, Moore et al34 also presented an 
Figure 1. Description of a closed-loop system. EEG indicates electroencephalogram.
Figure 2. Picture of the IVAC titrator (Becton, Dickinson, and 
Company, San Diego, CA), the first electronically controlled infusion 
pumps with fluid flow technology. The photograph is courtesy of 
Bob Butterfield, used with permission from Becton, Dickinson, and 
Company (San Diego, CA).
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innovative system for propofol-induced hypnosis 
control using reinforcement learning which is an 
artificial intelligence aiming to control biological 
systems more steadily. The incorporation of artificial 
intelligence in their algorithm showed promising 
results with significantly shorter periods of overshoot 
and more rapid achievement of steady state compared 
to a conventional proportional-integral-derivative 
controller.35 Lately, a multicenter randomized 
controlled trial confirmed that single closed-loop 
control for propofol outclasses manual infusion rate 
control.36 In addition, 2 recent meta-analyses listed 
available BIS-guided autonomous systems and 
concluded that they provided both better clinical 
performance and better safety compared to manual 
control.10,11
Multiple Closed-Loop System for General Anesthesia: 
MIMO. Although Liu et al12 were the first to 
demonstrate that a closed-loop system could control 
the delivery of both propofol and remifentanil with 
good results, from an engineering perspective, such a 
system is not a MIMO system because both propofol 
and remifentanil target concentration infusions 
change according to a single input variable, the 
BIS. Liu et al12 made the assumption that painful 
surgical stimuli induce small BIS variation, whereas 
reduction of the hypnosis depth causes wider BIS 
oscillations. Thereby, in the former situation, only 
remifentanil infusion rate change while in the latter 
case, both remifentanil and propofol infusion rate 
change. In their trial, robotic control of hypnosis 
and analgesia was deemed acceptable allowing 
a faster extubation time. Hemmerling et al13 have 
developed an innovative pharmacological robot using 
independent controlled variables for each component 
of anesthesia. Thus, this system is a proper MIMO. 
This autonomous system, also known as McSleepy, is 
able to administer simultaneously hypnosis, analgesia, 
and neuromuscular block from induction to emergence 
of anesthesia.18 A randomized controlled trial on 
186 patients indicates that McSleepy could deliver 
better control of both hypnosis and analgesia.13 Also, 
McSleepy has been shown to be robust for both complex 
cardiac procedures37 and telemedicine applications.38
Pharmacological Robots for Conscious Sedation
Single Closed-Loop System for Conscious Sedation. In 
1998, Mortier et al39 were the first to describe a closed-
loop system for propofol composed of a TCI system 
controlled by an adaptive model-based artificial 
intelligence. The system was tested on 10 patients 
who received a spinal block to undergo elective lower 
limb surgery. Patients, 48 years old on average, had 
an individualized BIS target value equivalent to a 
score of 1 on the Observer Assessment Alertness and 
Sedation scale,40 which corresponded on average to a 
BIS value of 64. All patients underwent the surgical 
procedure breathing spontaneously via a tight-fitting 
facemask. None became apneic during the automated 
administration of propofol and none had an oxygen 
saturation <90%. None of the patients reported either 
implicit or explicit awareness. In 2002, Leslie et al41 
conducted a similar investigation in 16 patients 
undergoing a colonoscopy. In their trial, they tested 
a pharmacological robot that uses a TCI system 
controlled by a proportional-integral-differential 
algorithm. Patients, 60 years old on average, had an 
individualized BIS target value equivalent to a score 
of 3 on the observer assessment alertness and sedation 
scale which corresponded on average to a BIS value of 
80. During the automated sedation no patient became 
apneic. The minimum oxygen saturation was 93%. 
This system proved to be efficient in maintaining the 
sedation target 75% of the closed-loop control time. 
However, the sedation target for maintenance was 
not reached using the closed-loop system but was 
obtained with manual increment.
Multiple Closed-Loop System for Conscious Sedation. 
In 2016, Zaouter et al42 published a landmark 
trial describing a closed-loop delivery system for 
propofol sedation integrating a decision support 
system specifically conceived to assist the anesthesia 
team. Using BIS, respiratory rate, and peripheral 
oxygen saturation as control variables and an 
infusion pump served as the actuator, this hybrid 
robot called hybrid sedation system (HSS) showed 
better maintenance of the target BIS value42 and 
fewer episodes of hypoxemia43 compared to manual 
administration. The HSS evaluated the hypnosis 
depth with BIS values every 5 seconds to determine 
the sedation depth. In contrast to Mortier et al39 and 
Leslie et al’s41 automated sedation system, the HSS 
does not encompass a TCI technology but uses other 
algorithms to guide the infusion rate by the BIS index. 
Another important feature of the HSS shown to be 
efficient is its decision support system conceived to 
help the anesthesiologist to detect and treat critical 
cardiorespiratory impairments.1 Future autonomous 
system for sedation will combine a closed-loop 
system with cognitive aids such as decision support 
system.
Pharmacological Robots for Hemodynamic 
Management
Optimal hemodynamic management aims to supply 
oxygenated blood with enough pressure to reach each 
part of every organ present in the human body. To do 
so, anesthesiologists’ armamentarium is grounded on 
4 types of pharmacologic agents: fluids, vasopressors, 
catecholamines, and vasodilator drugs.
Copyright © 2020 International Anesthesia Research Society. Unauthorized reproduction of this article is prohibited.
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Closed-Loop System for Goal-Directed Fluid Therapy. 
Computer assistance of intravenous resuscitation 
was one of the first clinical interventions attempted. 
In the 1970s, a group in Texas developed a closed-
loop system for fluid administration based on urine 
output.44,45 In the past 20 years, many measures have 
been used to direct fluid resuscitation, including 
mean arterial pressure,46,47 spectroscopy,48 pulse 
pressure variation and stroke volume variation,49 or a 
combination thereof.50
One of the challenges of fluid therapy is that, 
unlike other measures like heart rate or blood pres-
sure, “optimal” fluid status is neither clearly defined 
nor easily assessed.51,52 Despite these challenges, algo-
rithms can nevertheless be designed to mimic with 
high fidelity the way that clinicians administer fluid, 
particularly when guided by established algorithms 
like goal-directed fluid therapy.52 While the question 
of “optimal” fluid strategy remains open, closed-loop 
systems may in the meantime ensure that protocols 
that have been shown effective may be implemented 
with higher consistency than when implemented 
manually.53–56 Some authors of this narrative review 
have published numerous human trials using this 
type of closed-loop goal-directed fluid therapy algo-
rithm and have shown increased protocol adher-
ence,57–59 decreased length of hospital stay,58 and 
decreased postoperative complications60 in patients 
undergoing major surgery.
Several teams around the world are currently work-
ing on closed-loop fluid resuscitation algorithms.61–64 
Moreover, there have been early attempts to look at 
combining fluid resuscitation with other common 
resuscitation drugs like vasopressors.65,66 For the most 
part, many of these efforts are using independent, 
noncooperative controllers, but showing this is safe is 
a necessary step in the progression of these technolo-
gies.65,66 Finally, closed-loop fluid delivery systems 
have also been used as an “unbiased interventional-
ist” in studies examining the effects of different resus-
citation fluids.67,68
Closed-Loop System for Vasopressor Titration. Several 
retrospective studies highlighted the key role of blood 
pressure control in the operating room, and there is 
published evidence that the titration of vasopressors 
by hand is inefficient and inaccurate.69 Thus the 
development of a more effective titration system may 
be particularly clinically impactful and be the future 
for blood pressure management in both surgical 
and intensive care unit patients.70,71 Vasopressor 
administration, having a single “controlled” 
physiologic variable readily measured (arterial 
blood pressure), provides a more direct target than 
fluid therapy; it is another intervention that earlier 
researchers attempted to automate.72–74 However, there 
was little commercial development—likely due to a 
variety of factors, not the least of which is regulatory 
concerns and safety. More recently, some authors 
believe that such systems have a huge potential for 
the future.70,71 Available prototypes were developed 
for operating room and intensive care unit use,75–77 
obstetrics and spinal-induced hypotension,15,78,79 
and septic shock.80 Moreover, Libert et al81 in Paris 
developed and tested a closed-loop system that 
can administer vasopressors and fluids with good 
performance metrics.
Closed-Loop System for Catecholamines to Improve Cardiac 
Function. Cardiac function has not been studied 
much for pharmacological closed-loop systems. This 
may be a natural consequence of the properties of 
inotropic cardiac medications as well as difficulty 
in assessing ventricular contractility in an objective 
and continuous manner. In addition, many cardiac 
drugs have nonlinear effects, and ceiling effects 
are common and often occur at low infusion rates. 
The obvious exception is the implantable cardiac 
pacemaker. The most modern pacemakers are quite 
advanced containing many layers of autonomous 
systems that combine several algorithms governing 
their function, but this is an electrical system and not 
a pharmacologic one.82
Nevertheless, pharmacologic rate control of heart 
rate by automated systems has been done in cardiac 
stress tests.83 Inotropes have also been studied in at 
least 2 published manuscripts.84,85
Closed-Loop System for Vasodilators. Vasodilators, like 
vasopressors, have a directly measurable controlled 
variable and were thus also early autonomous system 
prototypes.86 Because of the relative infrequent need 
for vasodilation drips in clinical care, however, 
and the risks of overtreatment, there has not been 
much progression of this research. Two studies did 
explore titration of vasodilators via closed-loop for 
neurosurgery87 and cardiac surgery.88
MECHANICAL ROBOTS
Mechanical robots are designed to give support to the 
anesthesiologist. The 2 main areas of application to 
date are endotracheal intubation and regional.
In regard to intubation, a first trial involved the 
use of the DaVinci Surgical System in the perfor-
mance of 2 simulated fiberoptic intubations, which 
were both successful even if technically difficult due 
to the robot design with multiple robotic arms.89 The 
Kepler Intubation System90 is composed of 1 robotic 
arm linked to a standard videolaryngoscope in one 
end and remotely controlled by a joystick controlled, 
in turn, by a specific software and interface (Figure 3). 
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Intubations can be performed automatically or semi-
automatically, under direct vision or remotely: proce-
dural time ranged overall from 40 to 60 seconds in 90 
simulated intubations, all of which were successful 
on the first attempt.90 In a trial in 12 clinical patients, 
the Kepler Intubation System showed a success rate of 
91% with a mean procedural time of 93 seconds, with-
out complications.91 More recently, a research group 
from China developed a mechanical robot designed 
specifically for intubation.92 This research group con-
ducted an experimental animal study demonstrating 
that a mechanical robot remotely controlled could 
allow individual with no experience with endotra-
cheal intubation to achieve a higher first-pass rate 
and overall success rate by the robot system than 
with the standard direct laryngoscopy.92 However, the 
total intubation time using the mechanical robot was 
longer compared with the other group using a direct 
laryngoscopy (75 vs 53 seconds; P < .01).92
Robotic assistance with regional anesthesia has 
been tried via ultrasound-guided nerve block and 
placement of perineural catheter performed on a 
phantom using the DaVinci System, with the same 
constraints mentioned above for intubations.93 The 
Magellan system was developed to perform robot-
assisted ultrasound-guided nerve blocks by the use of 
a robotic arm with a nerve block needle at the end, 
guided by a joystick and controlled by custom soft-
ware and interface (Figure 4).94 A success rate of 100% 
was achieved on a standard ultrasound phantom94 
and subsequently in 13 patients undergoing popli-
teal block with a maximum procedural time of 4 min-
utes.95 This system could be integrated with software 
that allows for the automatic recognition of the nerve 
on the ultrasound image without human search.96 
While the system is still under development, the 
first results are promising.96 In addition, it has been 
recently shown that the use of robots for ultrasound-
guided nerve blocks is associated with faster learning 
and a lower intersubject variability than manual per-
formance in a simulated setting.97
COGNITIVE ROBOTS
Cognitive Robots: How Do They Work?
Cognitive robots in anesthesia are designed to provide 
support to an anesthesiologist in clinical decision-mak-
ing. They analyze various patient data elements to offer 
immediate pertinent clinical suggestions/reminders 
and specific up-to-date treatment options, typically 
enhancing compliance with guidelines. Cognitive 
robots, also known as clinical decision support sys-
tems (CDS), could be differentiated in 2 types, either 
expert-based build-in algorithms or nonknowledge 
based. Expert-based build-in algorithms systems use 
expert clinical knowledge to detect clinical events. In 
contrast, non–knowledge-based systems use artificial 
intelligence to develop algorithms from real clinical 
scenarios. For a more exhaustive description regarding 
clinical consideration of the CDS, we invite the readers 
to consult Nair et al’s review.98 The first cognitive robot 
tested clinically was in the early 50s. However, a more 
diffuse adoption of this type of cognitive aid has been 
possible via the introduction of anesthesia information 
management systems in the operating room.98 For clar-
ity, CDS could be divided into preoperative, intraoper-
ative, and postoperative system. For an extensive list of 
articles on CDS constantly updated the readers could 
access the following link: http://www.franklindexter.
net/bibliography_AIMS.htm.
Clinical decision support should be differentiated 
from closed-loop systems; they are in many ways 
at opposite ends of the automation implementation 
curve. CDS are cognitive aids for the clinician who 
then must implement suggestions provided by the 
system to perform an action. Conversely, a closed-
loop system works autonomously, and human inter-
vention is not necessary, except for the clinician 
directing the therapy by choosing targets and/or 
treatment goals. To date, no clinical automation in 
anesthesiology has been responsible for both imple-
mentation of therapy and choosing the target or goal 
of that therapy.
Preoperative Cognitive Robots
Smart Alarms for Early Detection of Abnormal Laboratory 
Values. Automated smart alarms for abnormal 
laboratory values in general medicine have been shown 
to improve patient outcome.99 In anesthesia, only 1 trial 
has demonstrated that CDS could be a helpful tool to 
prevent adverse events informing attending clinicians 
of abnormal preoperative laboratory values.100 
Figure 3. Picture of the Kepler Intubation System.
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However, evidence showing that improved patient 
outcome is possible using this type of CDS is missing.
Preoperative Reminder to Ensure Drug Administration 
Compliance. Before arrival for surgery patients 
who are receiving beta-blockers should continue 
to take their prescription to reduce perioperative 
cardiovascular morbidity and mortality after both 
cardiac and noncardiac surgery.101 Nair et al101 have 
conducted an investigation suggesting that CDS 
could be an excellent tool to ensure the observance 
of the administration of beta-blockers. Indeed, many 
modern electronic medical record systems include 
such reminders.
Dynamic Electronic Cognitive Checklist Aid. 
Implementation of a static surgical checklist has 
been shown to be associated with both a decrease 
in the incidence of perioperative complications 
and mortality.102 Recently, a trial conducted in 
anesthesia comparing a dynamic electronic cognitive 
checklist assistance using a CDS versus a standard 
checklist demonstrated that the group using a CDS 
performed more checklist items correctly.103 It could 
be inferred that such CDS could reduce perioperative 
complications. However, no study has investigated 
whether an anesthesia checklist using a CDS could 
improve patient outcome.
Intraoperative Cognitive Robots
Smart Alarms for Appropriate Perioperative Antibiotic 
Administration. Antibiotic injection before the surgical 
incision and intraoperative readministration, when 
appropriate, has been associated with improved 
patient outcome. Nair et al104 have developed a CDS 
that offers a more accurate identification of the most 
appropriate prophylactic antibiotics with the latest 
recommendations of dosing intervals.
Smart Alarms to Help Clinicians in Decision-Making. 
Cognitive robots have been successfully integrated 
into intraoperative alarms, creating “smart” alarm 
systems that can analyze several parameters 
simultaneously by artificial intelligence using rule-
based expert knowledge. The main advantage of 
these smart alarms is that they could lower the rate of 
false alarm.105
Better Compliance With Antiemetic Prophylaxis. Kappen 
et al106 have conducted a study showing that a CDS 
could help attending anesthesiologists to follow 
more strictly the recommendations related to optimal 
prophylaxis for nausea and vomiting. Using a CDS 
increased the number of antiemetic drugs prescribed 
when patients were at high risk compared to the 
group that did not benefit from the help of a cognitive 
robot.106 However, the rates of nausea and vomiting 
between the 2 groups were similar.
More Efficient Anesthetic Gas Delivery. Anesthetic gas 
wastage through inappropriate use of fresh gas flows 
may lead to a substantial increase in the cost of this 
drug. A simple CDS using smart alarms has been 
shown to significantly reduce anesthetic gas wastage 
saving more than $100,000 per year.107
More Efficient Billing Implementation. In addition to 
direct patient care, several studies have shown 
that CDS with the help of smart reminders could 
improve professional billing observance and 
reimbursement.98
FUTURE DIRECTIONS
Given the current applications of autonomous sys-
tems and robotics in anesthesiology, we can make 
some educated hypotheses about future applications 
of these technologies.
Figure 4. Picture of the Magellan 
System (popliteal sciatic nerve 
block performed via a posterior 
approach).
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For the past 20 years, several research groups 
(including our own) have created and developed dif-
ferent automated closed-loop systems to control the 
administered amount of hypnotic, analgesic, fluid and 
vasoactive drugs, among others. An unexplored area 
until recently was the use of simultaneous closed-loop 
systems during major surgeries. In 2016, Joosten et 
al66 described the first application of automated anes-
thesia and fluid management based on a combination 
of several physiological variables (BIS, stroke volume, 
and stroke volume variation) using 2 independent 
closed-loop systems in a patient undergoing high-risk 
surgery. Two years later, they tested the same strategy 
in a small cohort of 13 high-risk patients undergoing 
major vascular surgeries and showed the feasibility of 
2 independent controllers to maintain their targets for 
the majority of the surgical case time without harmful 
cross-interference.108
If published articles on closed-loop systems have 
demonstrated that such automated systems can bet-
ter maintain the target variable in the desired range, 
there is still no data on whether it can improve patient 
outcomes. Joosten et al109 have very recently demon-
strated that among older patients scheduled for non-
cardiac surgery, automated management of anesthetic 
depth, cardiac blood flow, and protective lung venti-
lation using 3 independent controllers outperformed 
manual control of these variables. In addition, as a 
result of the improved management, the automated 
strategy may have had an impact on delayed neuro-
cognitive recovery. Importantly, in the above articles, 
each closed-loop still operated independently, guided 
only by its own respective inputs (BIS for the propofol 
and remifentanil; stroke volume and stroke volume 
variation for the fluid boluses). In an ideal situation, 
there would be cross-communication such that a fall 
in blood pressure may cause a reduction in the anes-
thetic administration, for example, if there was wiggle 
room in the BIS value.
One area that is obviously ripe for exploration with 
automated systems is research specifically designed 
around the unbiased and consistent implementation 
of interventions by these systems. An existing exam-
ple is the use of a closed-loop fluid administration 
system as an unbiased interventionalist to answer 
the question of whether crystalloids or colloids were 
superior for intraoperative goal-directed fluid ther-
apy.67,68 Before the automation of such tasks, com-
plete removal of bias from implementation of such 
protocols was not possible. There are many avenues 
of exploration, for example, in which determination 
of optimal vasopressor therapy has been historically 
hampered by challenges with study group overlap 
and low time-in-target.110 With closed-loop vasopres-
sor systems, clearer benefits and limitations may be 
explored.
Another possibly farther future possibility is sys-
tems, which choose both appropriate, targets, and 
manage the interventions to reach the target. As 
noted above, to date, there are no clinical automation 
systems that both choose the clinical targets for ther-
apy and implement that therapy. It is unlikely that 
we will see such systems in the near term, as in many 
cases, the appropriate clinical targets are still not well 
understood. Nevertheless, eventually, we will start to 
see the emergence of not just systems that provide 
advice on the appropriate actions but are capable of 
independently implementing that action.
Another likely future direction would be the move-
ment from automation based on current conditions to 
“predictive therapy.” Even simple closed-loop con-
trollers will make “predictions” about the immedi-
ate future states of the patient; “predictive therapy,” 
however, refers to longer-term predictions than this. 
The basic concept behind predictive therapy is that if 
one could accurately predict whom, when, and why 
patients develop a problem during the perioperative 
period, then effective preemptive treatments could be 
started in advance to improve postoperative outcome 
and more effectively use health care resources. One 
team from Pittsburgh in the United States has already 
developed, validated, and tested real-time intraopera-
tive risk prediction tools based on electronic health 
record data and high-fidelity physiological waveforms 
to predict cardiopulmonary instability in the intensive 
care unit.111 More recently, another team from London 
developed the “Artificial Intelligence Clinician” to 
learn optimal treatment strategies for sepsis in inten-
sive care.112 The authors demonstrated that using their 
“Artificial Intelligence Clinician” allowed better treat-
ment selection which could lead to lower mortality 
rates in patients.112 When it comes to the operating 
theatre, collection of real-time high-fidelity physi-
ological waveform data streams and their integration 
with patient demographics from the electronic health 
record to build large data sets now allows the deri-
vation of actionable information based on machine-
learning analytics. This, in turn, allows the system to 
display this information in real time at the bedside to 
drive clinical decision support in this specific setting. 
At present in the operating arena, anesthesiologists are 
surrounded by a multitude of hemodynamic monitor-
ing devices and electronic medical records; machine-
learning–derived, actionable alerts based on this wide 
array of information could be very useful to offer a 
truly personalized medical care. Recently, Hatib et al113 
demonstrated that high-resolution analysis of arte-
rial pressure waveforms could be analyzed to pro-
duce a new parameter (“hypotension predictive 
index”), which has been shown to predict hypoten-
sion 10–15 minutes before any hypotension occurring 
in >80% of hypotensive episodes. This has recently 
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been confirmed by Davis et al114 who have analyzed 
retrospective data from patients scheduled for major 
surgeries. Another team from New York successfully 
demonstrated the feasibility of machine-learning mod-
els to predict postinduction hypotension with similar 
efficacy.115 Machine learning seems an appealing strat-
egy to revolutionize the effect that computational sys-
tems have on process measure and outcomes. We may 
expect that one day, individualized administration of 
drugs will be performed by intelligent technologies, 
which would compare the patients they are currently 
taking care of to data from prior patients with simi-
lar demographics and previous drug responses. Thus, 
the responses of individual patients to a given phar-
macologic agent may be more accurately predictable 
than presently. Finally, more sophisticated analytics 
involving machine learning could be used to better 
explore the interactions between disparate closed-loop 
systems working concurrently. It has to be stated that 
the technologies described in this article are still con-
sidered experimental medical devices and can only 
become clinically acceptable if considerable thought 
and effort are put into safety. This particular topic was 
recently covered in a special article by members of the 
Center for Devices and Radiological Health at the US 
Food and Drug Administration.116 Based on this and 
ongoing development, we expect that as early as 2020, 
the regulatory acceptance of these technologies may 
begin to occur. The regulatory approval process for 
such devices will take time and significant effort from 
thought leaders and industry and clinical safety and 
efficacy will need to be shown, all of which will require 
significant investment of resources for the develop-
ment of automated systems. To reach this goal, clini-
cians should understand basic principles, potential 
advantages, and limitations of closed-loop system.2,117 
To the extent possible, these systems should not be a 
“blackbox”; clinicians should have full transparency 
into how adjustments are made, full understanding 
of the algorithm and its controlled variables, and have 
an adequate understanding of potential failures and 
risk to use it appropriately and safely. While every 
anesthesiologist to use the device may not need this 
level of detail, the technophiles among us should have 
access so better vet the performance of these systems 
and refine them over time. Moreover, clinician input 
will be essential for commercial entities developing 
these systems because it is essential for establishing 
control system performance metrics and their clini-
cal relevance. Consensus standards developed by 
national and international anesthesia societies may be 
an appealing strategy to warrant a wide clinical accep-
tance and standardized comparison between alterna-
tive algorithms.
Finally, as previously noted, attention will even-
tually need to be focused on the codevelopment and 
coordination of multiple closed-loop systems into a 
single robust fully autonomous closed-loop system. 
If appropriately developed and validated, such a sys-
tem may even be incorporated into an optimized user 
interface of the anesthesia workstation machine.
LIMIT TO EMBRACE ROBOTIC ANESTHESIA IN 
CLINICIANS’ EVERYDAY PRACTICE
Anesthesiologists have always been early adopters of 
novel technologies, and open and comfortable incor-
porating new technological innovations to improve 
patient safety. However, when it comes to periopera-
tive automation, a regular and particularly frequent 
point of resistance is the fear that automation may 
replace skilled anesthetists in the operating room. 
“Will closed-loop systems eventually replace provid-
ers?” is a question each of the authors has been asked 
when we give lectures on this topic around the world. 
While understandable—automation has been feared 
in virtually every form in which it was initially intro-
duced—any practitioner familiar with the current 
and future state of these technologies will likely agree 
that such fearful propositions are severely overstated. 
The future of anesthesia is not “man versus machine” 
but rather man with machine. A more appropriate 
question would be: “What benefit could automation 
have on my daily clinical practice and how could 
this system improve patient care while also reducing 
mundane clinical tasks?” We do not yet have a com-
plete answer to this question but research on the sub-
ject is being reported at an unprecedented rate, and 
recent evidence shows that combining several robots 
together could potentially have an impact on patient 
outcome.109
Robotic anesthesia, closed-loop feedback control of 
anesthesia, has been used in numerous research set-
tings. There is obviously still a significant step from 
performance in these settings to daily performance, 
particularly in the hands of clinicians with little or no 
experience with such technologies. Like robotic tech-
nology in manufacturing industries, rigorous testing 
needs to be done before such commercial products 
are available, especially in the medical field. Because 
closed-loop systems have different components, each 
component might fail, connectivity might be com-
promised, software failure might occur, and above 
all human failure might lead to system failure, for 
example, wrong input of initial patient or surgery-
related data. Safe checks could be the presence of a 
human controller, operator to continuously check for 
plausibility, the possibility to manually override the 
system—including going back to fully automated 
mode—and continuous internal safety checks of the 
system itself. One can imagine that these are impor-
tant safety considerations, which will require signifi-
cant manpower and financial resources to address.
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CONCLUSIONS
The integration of robots into clinical practice aims 
at assisting the clinician. The goal is to increase 
treatment accuracy, improve patient safety, and 
reduce workload. The final objective is to allow the 
anesthesiologist to focus on tasks requiring human 
intelligence. Autonomous systems for general anes-
thesia, sedation, and manual tasks in combination 
with cognitive help are not inferior to the perfor-
mance of anesthesiologists and may eventually 
allow superior performance. Robots in anesthesia 
are made to assist anesthesiologists providing a 
technological mental and physical “augmenta-
tion” to the clinician allowing a “smart” distribu-
tion of the workload. The goal of automation is 
not to replace a qualified care provider normally 
required for a particular task or intervention, but 
rather to assist a standard provider in application 
of an intervention ensuring that the highest quality 
of care is being used consistently and effectively for 
all patients.
Future studies will determine whether they could 
have a clinical impact on outcomes compared to anes-
thesia conducted without the help of autonomous 
systems. E
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